{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:41:55Z","timestamp":1790440915505,"version":"4.1.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Long Term Health Education and Training program from the United States Army"},{"DOI":"10.13039\/100005615","name":"Beth Israel Deaconess Medical Center","doi-asserted-by":"publisher","award":["R33AI119114"],"award-info":[{"award-number":["R33AI119114"]}],"id":[{"id":"10.13039\/100005615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005615","name":"Beth Israel Deaconess Medical Center","doi-asserted-by":"publisher","award":["R01 AI099122"],"award-info":[{"award-number":["R01 AI099122"]}],"id":[{"id":"10.13039\/100005615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005615","name":"Beth Israel Deaconess Medical Center","doi-asserted-by":"publisher","award":["R21 AI130434"],"award-info":[{"award-number":["R21 AI130434"]}],"id":[{"id":"10.13039\/100005615","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1093\/jac\/dkz012","type":"journal-article","created":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T20:10:07Z","timestamp":1547323807000},"page":"1311-1316","source":"Crossref","is-referenced-by-count":31,"title":["Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae"],"prefix":"10.1093","volume":"74","author":[{"given":"Stefan","family":"Riedel","sequence":"first","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Vijayakumar","sequence":"additional","affiliation":[{"name":"Northeastern University, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gretchen","family":"Berg","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA"},{"name":"Department of Pathology and Ancillary Laboratory Services, Carl R. Darnall Army Medical Center, Fort Hood, TX, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth P","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E","family":"Kirby","sequence":"additional","affiliation":[{"name":"Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA"},{"name":"Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,1,27]]},"reference":[{"key":"2019042309335273000_dkz012-B1","doi-asserted-by":"crossref","first-page":"e0143304.","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"2019042309335273000_dkz012-B2","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1136\/sti.2010.042648","article-title":"The Gonococcus fights back: is this time a knock out?","volume":"86","author":"Lewis","year":"2010","journal-title":"Sex Transm Infect"},{"key":"2019042309335273000_dkz012-B3","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1586\/eri.09.63","article-title":"Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae","volume":"7","author":"Tapsall","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"key":"2019042309335273000_dkz012-B4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2217\/fmb.12.117","article-title":"Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea","volume":"7","author":"Unemo","year":"2012","journal-title":"Future Microbiol"},{"key":"2019042309335273000_dkz012-B5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/sti.2010.044164","article-title":"European surveillance of antimicrobial resistance in Neisseria gonorrhoeae","volume":"86","author":"Cole","year":"2010","journal-title":"Sex Transm Infect"},{"key":"2019042309335273000_dkz012-B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6507a1","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility surveillance\u2014the Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014","volume":"65","author":"Kirkcaldy","year":"2016","journal-title":"MMWR Surveill Summ"},{"key":"2019042309335273000_dkz012-B7","doi-asserted-by":"crossref","first-page":"iv57","DOI":"10.1136\/sextrans-2012-050910","article-title":"Moving forward in tackling antimicrobial resistance: WHO actions","volume":"89","author":"Lusti-Narasimhan","year":"2013","journal-title":"Sex Transm Infect"},{"key":"2019042309335273000_dkz012-B8"},{"key":"2019042309335273000_dkz012-B9","doi-asserted-by":"crossref","first-page":"e02047-16","DOI":"10.1128\/AAC.02047-16","article-title":"In vitro activity of gepotidacin (GSK2140944) against Neisseria gonorrhoeae","volume":"61","author":"Farrell","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diagmicrobio.2016.03.007","article-title":"Effect of susceptibility testing conditions on the in vitro antibacterial activity of ETX0914","volume":"87","author":"Giacobbe","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019042309335273000_dkz012-B11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/cid\/civ478","article-title":"A phase 2 trial of oral solithromycin 1200 mg or 1000 mg as single-dose oral therapy for uncomplicated gonorrhea","volume":"61","author":"Hook","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2019042309335273000_dkz012-B12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ijantimicag.2016.05.018","article-title":"In vitro growth of multidrug-resistant Neisseria gonorrhoeae isolates is inhibited by ETX0914, a novel spiropyrimidinetrione","volume":"48","author":"Papp","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"2019042309335273000_dkz012-B13","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1128\/JCM.02250-15","article-title":"Determination of disk diffusion and MIC quality control guidelines for solithromycin, a novel fluoroketolide antibacterial, against Neisseria gonorrhoeae","volume":"53","author":"Riedel","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2019042309335273000_dkz012-B14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"2019042309335273000_dkz012-B15","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1093\/jac\/dkx147","article-title":"Antimicrobial susceptibility of clinical isolates of Neisseria gonorrhoeae to alternative antimicrobials with therapeutic potential","volume":"72","author":"Lagace-Wiens","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2019042309335273000_dkz012-B16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"2019042309335273000_dkz012-B17","doi-asserted-by":"crossref","first-page":"216.","DOI":"10.1186\/s12866-016-0838-9","article-title":"Time\u2013kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae","volume":"16","author":"Foerster","year":"2016","journal-title":"BMC Microbiol"},{"key":"2019042309335273000_dkz012-B18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/OLQ.0b013e3181bf575c","article-title":"Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007","volume":"37","author":"Brown","year":"2010","journal-title":"Sex Transm Dis"},{"key":"2019042309335273000_dkz012-B19","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1128\/JCM.35.11.2985-2988.1997","article-title":"Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods","volume":"35","author":"Daly","year":"1997","journal-title":"J Clin Microbiol"},{"key":"2019042309335273000_dkz012-B20","doi-asserted-by":"crossref","first-page":"7518","DOI":"10.1128\/AAC.01907-16","article-title":"Gentamicin susceptibility among a sample of multidrug-resistant Neisseria gonorrhoeae isolates in India","volume":"60","author":"Bala","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B21","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/cid\/ciu521","article-title":"The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea","volume":"59","author":"Kirkcaldy","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2019042309335273000_dkz012-B22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/OLQ.0000000000000693","article-title":"Susceptibility of Neisseria gonorrhoeae to Gentamicin\u2014Gonococcal Isolate Surveillance Project, 2015-2016","volume":"45","author":"Mann","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2019042309335273000_dkz012-B23","first-page":"771","article-title":"[Ototoxicity of spectinomycin (author\u2019s transl)]","volume":"29","author":"Akiyoshi","year":"1976","journal-title":"Jpn J Antibiot"},{"key":"2019042309335273000_dkz012-B24","doi-asserted-by":"crossref","first-page":"10984","DOI":"10.1073\/pnas.1204073109","article-title":"Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin","volume":"109","author":"Matt","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019042309335273000_dkz012-B25","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1128\/AAC.01775-12","article-title":"Neisseria gonorrhoeae strain with high-level resistance to spectinomycin due to a novel resistance mechanism (mutated ribosomal protein S5) verified in Norway","volume":"57","author":"Unemo","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cid\/cir838","article-title":"Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia","volume":"54","author":"Pulcini","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2019042309335273000_dkz012-B27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/jac\/dkq408","article-title":"Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates","volume":"66","author":"Livermore","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"2019042309335273000_dkz012-B28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2885.1985.tb00930.x","article-title":"Clinical pharmacology of apramycin in calves","volume":"8","author":"Ziv","year":"1985","journal-title":"J Vet Pharmacol Ther"},{"key":"2019042309335273000_dkz012-B29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2885.1995.tb00602.x","article-title":"Serum and milk concentrations of apramycin in lactating cows, ewes and goats","volume":"18","author":"Ziv","year":"1995","journal-title":"J Vet Pharmacol Ther"},{"key":"2019042309335273000_dkz012-B30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2885.2004.00598.x","article-title":"Pharmacokinetics of gentamicin and apramycin in turkeys roosters and hens in the context of pharmacokinetic-pharmacodynamic relationships","volume":"27","author":"Haritova","year":"2004","journal-title":"J Vet Pharmacol Ther"},{"key":"2019042309335273000_dkz012-B31","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/jo00874a003","article-title":"Apramycin, a unique aminocyclitol antibiotic","volume":"41","author":"O\u2019Connor","year":"1976","journal-title":"J Org Chem"},{"key":"2019042309335273000_dkz012-B32","first-page":"324","article-title":"Nebramycin, a new broad-spectrum antibiotic complex. II. Description of Streptomyces tenebrarius","volume":"7","author":"Higgins","year":"1967","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B33","first-page":"314","article-title":"Nebramycin, a new broad-spectrum antibiotic complex. I. Detection and biosynthesis","volume":"7","author":"Stark","year":"1967","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1432-1033.1979.tb13295.x","article-title":"Effects of apramycin, a novel aminoglycoside antibiotic on bacterial protein synthesis","volume":"99","author":"Perzynski","year":"1979","journal-title":"Eur J Biochem"},{"key":"2019042309335273000_dkz012-B35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.diagmicrobio.2017.03.006","article-title":"In vitro apramycin activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa","volume":"88","author":"Kang","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019042309335273000_dkz012-B36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.diagmicrobio.2016.09.002","article-title":"Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae","volume":"86","author":"Smith","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019042309335273000_dkz012-B37","doi-asserted-by":"crossref","first-page":"33.","DOI":"10.15585\/mmwr.mm6601a7","article-title":"Notes from the field: pan-resistant New Delhi metallo-\u03b2-lactamase-producing Klebsiella pneumoniae\u2014Washoe County, Nevada, 2016","volume":"68","author":"Chen","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2019042309335273000_dkz012-B38","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"2019042309335273000_dkz012-B39","doi-asserted-by":"crossref","first-page":"2275.","DOI":"10.3389\/fmicb.2017.02275","article-title":"In vitro activity of neomycin, streptomycin, paromomycin and apramycin against carbapenem-resistant Enterobacteriaceae clinical strains","volume":"8","author":"Hu","year":"2017","journal-title":"Front Microbiol"},{"key":"2019042309335273000_dkz012-B40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1179\/1973947814Y.0000000190","article-title":"Prevalence of 16S rRNA methylase, modifying enzyme, and extended-spectrum \u03b2-lactamase genes among Acinetobacter baumannii isolates","volume":"27","author":"Liu","year":"2015","journal-title":"J Chemother"},{"key":"2019042309335273000_dkz012-B41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.diagmicrobio.2018.05.018","article-title":"Evaluation of apramycin activity against methicillin-resistant, methicillin-sensitive, and vancomycin-intermediate Staphylococcus aureus clinical isolates","volume":"92","author":"Truelson","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2019042309335273000_dkz012-B42","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1089\/adt.2016.701","article-title":"Validation of a high-throughput screening assay for identification of adjunctive and directly acting antimicrobials targeting carbapenem-resistant Enterobacteriaceae","volume":"4","author":"Smith","year":"2016","journal-title":"Assay Drug Dev Technol"},{"key":"2019042309335273000_dkz012-B43","doi-asserted-by":"crossref","first-page":"e0285","DOI":"10.1128\/AAC.02585-17","article-title":"Efficacy of apramycin against multidrug-resistant Acinetobacter baumannii in the murine neutropenic thigh model","volume":"62","author":"Kang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B44","doi-asserted-by":"crossref","first-page":"6938","DOI":"10.1128\/AAC.03239-14","article-title":"In vivo efficacy of apramycin in murine infection models","volume":"58","author":"Meyer","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B45"},{"key":"2019042309335273000_dkz012-B46","volume-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically\u2014Tenth Edition: M07","year":"2015"},{"key":"2019042309335273000_dkz012-B47","volume-title":"Methods for Determining Bactericidal Activity of Antimicrobial Agents: M26-A","year":"1999"},{"key":"2019042309335273000_dkz012-B48","doi-asserted-by":"crossref","first-page":"e00873-18","DOI":"10.1128\/AAC.00873-18","article-title":"Synergistic activity of colistin-containing combinations against colistin-resistant Enterobacteriaceae","volume":"62","author":"Brennan-Krohn","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1574-6968.2007.00776.x","article-title":"A fully defined, clear and protein-free liquid medium permitting dense growth of Neisseria gonorrhoeae from very low inocula","volume":"273","author":"Wade","year":"2007","journal-title":"FEMS Microbiol Lett"},{"key":"2019042309335273000_dkz012-B50","volume-title":"The BLAST Sequence Analysis Tool","author":"Madden","year":"2013"},{"key":"2019042309335273000_dkz012-B51","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/AAC.00419-13","article-title":"The comprehensive antibiotic resistance database","volume":"57","author":"McArthur","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mib.2015.07.004","article-title":"Bioinformatics of antimicrobial resistance in the age of molecular epidemiology","volume":"27","author":"McArthur","year":"2015","journal-title":"Curr Opin Microbiol"},{"key":"2019042309335273000_dkz012-B53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1128\/CMR.00047-06","article-title":"Setting and revising antibacterial susceptibility breakpoints","volume":"20","author":"Turnidge","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"2019042309335273000_dkz012-B54","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jac\/3.4.323","article-title":"The bactericidal action of spectinomycin on Neisseria gonorrhoeae","volume":"3","author":"Ward","year":"1977","journal-title":"J Antimicrob Chemother"},{"key":"2019042309335273000_dkz012-B55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1128\/AAC.14.1.69","article-title":"Enzymatic modification of aminoglycoside antibiotics: 3-N-acetyltransferase with broad specificity that determines resistance to the novel aminoglycoside apramycin","volume":"14","author":"Davies","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"2019042309335273000_dkz012-B57","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1093\/jac\/dks235","article-title":"Unusual small plasmids carrying the novel resistance genes dfrK or apmA isolated from methicillin-resistant or -susceptible staphylococci","volume":"67","author":"Kadlec","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"2019042309335273000_dkz012-B58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/AAC.01124-10","article-title":"Novel apramycin resistance gene apmA in bovine and porcine methicillin-resistant Staphylococcus aureus ST398 isolates","volume":"55","author":"Fessler","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B59","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1086\/518605","article-title":"16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides","volume":"45","author":"Doi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2019042309335273000_dkz012-B60","doi-asserted-by":"crossref","first-page":"7791","DOI":"10.1093\/nar\/gkq627","article-title":"Structural insights into the function of aminoglycoside-resistance A1408 16S rRNA methyltransferases from antibiotic-producing and human pathogenic bacteria","volume":"38","author":"Macmaster","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2019042309335273000_dkz012-B61","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1128\/AAC.00926-07","article-title":"Novel plasmid-mediated 16S rRNA m1A1408 methyltransferase, NpmA, found in a clinically isolated Escherichia coli strain resistant to structurally diverse aminoglycosides","volume":"51","author":"Wachino","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2019042309335273000_dkz012-B62","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/MMBR.57.1.138-163.1993","article-title":"Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes","volume":"57","author":"Shaw","year":"1993","journal-title":"Microbiol Rev"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/74\/5\/1311\/28501358\/dkz012.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,10]],"date-time":"2022-09-10T05:05:14Z","timestamp":1662786314000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/74\/5\/1311\/5303224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,27]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2019,1,27]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkz012","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2019,1,27]]}}}